News

AddToAny

Google+ Facebook Twitter Twitter

Protein that protects against Lyme Disease

Yale scientists have discovered a protein that helps protect hosts from infection with the tick-borne spirochaete that causes Lyme Disease.

Yale scientists have discovered a protein that helps protect hosts from infection with the tick-borne spirochaete that causes Lyme Disease.

The finding may help diagnose and treat the infection, they report.

Lyme Disease is endemic in many parts of the UK – particularly in woodland or heath-land areas – and is transmitted by ticks infected with the spirochaete Borrelia burgdorferi

The Yale team expressed more than 1000 human genes in yeast and analysed their interactions with 36 samples of B. burgdorferi

The course of the disease varies among individuals, with the majority experiencing mild symptoms easily treated by antibiotics. However, in some cases of untreated Lyme the infection can spread to the heart, joints, nervous system, and other organs.

For the study, the Yale team expressed more than 1000 human genes in yeast and analysed their interactions with 36 samples of B. burgdorferi. They found that one protein, Peptidoglycan Recognition Protein 1 (PGLYRP1), acts like an early warning signal to the immune system when exposed to the bacteria. When exposed to the Lyme spirochaete, mice lacking PGLYRP1 had much higher levels of B. burgdorferi than mice with the protein and showed signs of immune system dysfunction, the researchers report. 

bit.ly/38xM2QV

Image Credit: Shutterstock

Related Articles

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research-CREDIT_istock-1293772951

Equity, diversity and inclusion for all

Jemma Shead, a Senior Biomedical Scientist at Synnovis and IBMS EDI Working Group member, on how and why you should get involved with EDI.

adeno associated virus capsid-Image Credit | Science Photo Library - c0142837

Examining the medical mystery of child hepatitis outbreak

A study has shed light on an unexpected wave of severe acute hepatitis cases in 2022, amid the backdrop of the ongoing global COVID-19 pandemic.

clostridioides difficile bacteria-Image Credit | Science Photo Library - c0016337

Faecal microbiota transplant for C. diff

In the first comprehensive US evidence-based guideline on the use of faecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends faecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

pseudomonas aeruginosa bacteria Image-Credit | Science Photo Library - f0381226

Tackling priority pathogen with phages

A new study describes the use of phage therapy to eradicate multidrug-resistant Pseudomonas aeruginosa infections in vivo with important new implications for antibiotic resistance.

Top